CSBR
CHAMPIONS ONCOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$5.15
+1.28%Forward multiples
Based on analyst estimates
- P/E forward
- 46.77x
- P/E 2026E
- 50.00x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 18.39x
- Price / sales
- 1.18x
- Price / cash flow
- -12.87x
Enterprise value
- Enterprise value
- $78.8M
- EV / sales
- 1.30x
- EV / EBITDA
- 176.26x
- EV / EBIT
- -75.61x
- Market cap
- $71.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026